Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

about

Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.Identification of CSF biomarkers by proteomics in Guillain-Barré syndrome.

P2860

Q47289931-77B00C05-00ED-4C1A-88A9-28A3F2687679 Q55091771-20E58673-4EA6-436B-82E5-0C7B63D774E6

P2860

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

Item

http://www.wikidata.org/entity/Q39227455

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@en

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@nl

type

Item

label

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@en

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@nl

prefLabel

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@en

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@nl

P1476

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

@en

P2093

Alex McConnachie

http://www.w3.org/2001/XMLSchema#string

Amy I Davidson

http://www.w3.org/2001/XMLSchema#string

Arup Mallik

http://www.w3.org/2001/XMLSchema#string

Govind Chavada

http://www.w3.org/2001/XMLSchema#string

Hugh J Willison

http://www.w3.org/2001/XMLSchema#string

James Overell

http://www.w3.org/2001/XMLSchema#string

John A Goodfellow

http://www.w3.org/2001/XMLSchema#string

Michael P Lunn

http://www.w3.org/2001/XMLSchema#string

Susan K Halstead

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of current diagnostic criteria for Guillain-Barré syndrome

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

Intravenous immunoglobulin for Guillain-Barré syndrome

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

The immunobiology of Guillain-Barré syndromes.

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.

Controlled trial prednisolone in acute polyneuropathy.

P304

4-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JNS.12194

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pieter A van Doorn

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27801990

http://www.w3.org/2001/XMLSchema#string

P921

Guillain–Barré Syndrome

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

about

P2860

P2860

Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921